Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Steven Ferrucci

Optometrist Sepulveda, CA Doctor of Optometry

NPI 1225053267 CMS profile 237205

16111 Plummer St # 112E, Sepulveda, CA 91343

Open in the dashboard

General payments

$272,179

350 records reported · program years 2019–2025

Research payments

$20,311

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Steven Ferrucci of Sepulveda, CA is reported in the CMS Open Payments database as having received $272,179 across 350 general payments and $20,311 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $43,023 42
2024 General $24,036 40
2023 General $22,162 27
2022 General $23,557 49
2021 General $34,890 31
2021 Research $1,200 1
2020 General $22,489 28
2020 Research $19,111 1
2019 General $102,023 133

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Ferrucci
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Steven Ferrucci were reported at $43,023. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Steven Ferrucci Optometrist median Middle half National median
2019 $102,023 $159 $67–$371 $163
2020 $22,489 $72 $29–$165 $114
2021 $34,890 $125 $46–$292 $132
2022 $23,557 $162 $66–$374 $149
2023 $22,162 $177 $72–$406 $160
2024 $24,036 $188 $77–$427 $164
2025 $43,023 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Apellis Pharmaceuticals, Inc. $43,239 40 payments
  2. Alcon Vision LLC $40,388 80 payments
  3. Astellas Pharma US Inc $38,649 56 payments
  4. MacuLogix, Inc. $33,693 23 payments
  5. Genentech USA, Inc. $32,197 49 payments
  6. Regeneron Healthcare Solutions, Inc. $29,758 56 payments
  7. LKC Technologies, Inc. $26,543 14 payments
  8. Optovue, Inc. $12,869 10 payments
  9. Bausch & Lomb Americas Inc. $5,518 5 payments
  10. F. Hoffmann-La Roche AG $4,841 2 payments
  11. Other $4,485 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $84,580 53 payments
  2. Consulting Fee $67,707 36 payments
  3. Honoraria $40,422 14 payments
  4. Travel and Lodging $34,627 127 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $32,137 8 payments
  6. Food and Beverage $12,706 112 payments
Products named General payments · program years 2019–2025
  1. Izervay $34,883 46 payments
  2. DAILIES $34,400 46 payments
  3. AdaptDx $33,693 23 payments
  4. Lucentis $32,197 49 payments
  5. EYLEA $30,938 57 payments
  6. Syfovre $29,060 27 payments
  7. RETeval $17,250 1 payment
  8. AngioVue $12,678 7 payments
  9. Non-Covered Product $4,841 2 payments
  10. Foresee Home $500 1 payment
  11. Other $1,453 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. F. Hoffmann-La Roche AG $20,311 2 payments

Records

352 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record